ArticleBMC research notes2026
A universal indel filtering workflow for both long-read and short-read NGS data.
Article in BMC research notes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate detection of insertions and deletions (indels) is critical for applications in disease genomics, population genetics, and personalized healthcare. Despite advancements in sequencing technologies, indel detection remains challenging, particularly in difficult-to-map genomic regions. In this study, we present a universal machine learning-based filtering workflow that significantly improves indel detection accuracy for both long-read and short-read sequencing data, utilizing only publicly available genomic annotation datasets, eliminating the need for sequencing workflow-specific information, such as read depth. Our method (a gradient-boosting classifier powered by XGBoost) enhances precision by ~ 26% for long-read and ~ 24% for short-read data while maintaining high recall rates (~ 90%). We validate our approach using the Genome in a Bottle (GIAB) dataset and 62 indel call sets from the precisionFDA Truth Challenge V2, demonstrating its effectiveness in handling complex genomic regions and diverse sequencing workflows. Our tool is open-access and workflow-agnostic, making it a valuable resource for improving indel calling accuracy across various applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.